Trexquant Investment LP Makes New Investment in Teleflex Incorporated (NYSE:TFX)

Trexquant Investment LP acquired a new stake in Teleflex Incorporated (NYSE:TFX) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 23,394 shares of the medical technology company’s stock, valued at approximately $4,164,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of TFX. Headlands Technologies LLC acquired a new position in Teleflex in the fourth quarter valued at approximately $29,000. Avior Wealth Management LLC increased its holdings in shares of Teleflex by 81.2% during the 4th quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company’s stock valued at $50,000 after purchasing an additional 125 shares in the last quarter. IFP Advisors Inc increased its holdings in shares of Teleflex by 238.5% during the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock valued at $55,000 after purchasing an additional 217 shares in the last quarter. Exchange Traded Concepts LLC lifted its stake in shares of Teleflex by 38.2% in the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock valued at $61,000 after purchasing an additional 94 shares during the period. Finally, R Squared Ltd purchased a new stake in Teleflex during the fourth quarter worth $64,000. 95.62% of the stock is owned by institutional investors and hedge funds.

Teleflex Trading Down 4.4 %

Shares of TFX stock opened at $131.93 on Friday. Teleflex Incorporated has a fifty-two week low of $128.55 and a fifty-two week high of $249.91. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. The stock’s fifty day moving average is $154.86 and its two-hundred day moving average is $186.65. The firm has a market capitalization of $6.12 billion, a P/E ratio of 26.23, a PEG ratio of 1.73 and a beta of 1.19.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating analysts’ consensus estimates of $3.86 by $0.03. The business had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.03%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex’s dividend payout ratio is currently 95.77%.

Analysts Set New Price Targets

TFX has been the subject of a number of analyst reports. Bank of America downgraded shares of Teleflex from a “neutral” rating to an “underperform” rating and decreased their price objective for the stock from $235.00 to $140.00 in a research report on Tuesday, March 4th. Piper Sandler reiterated a “neutral” rating and set a $140.00 price target (down previously from $255.00) on shares of Teleflex in a research report on Friday, February 28th. Morgan Stanley cut their price objective on Teleflex from $275.00 to $191.00 and set an “overweight” rating for the company in a research report on Wednesday, March 5th. Wells Fargo & Company decreased their target price on Teleflex from $214.00 to $146.00 and set an “equal weight” rating on the stock in a research report on Friday, February 28th. Finally, Citizens Jmp lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $182.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.